In 2016, Kwak et al. used solid-state nanopore to study the interaction between the anti-cancer therapeutic p53 transactivation domain (p53TAD), MDM2, and its inhibitory effect on Nutlin-3, a small-molecule MDM2 antagonist [87]. This evidence concerns the gene MDM2 and cancer.